These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
275 related articles for article (PubMed ID: 22310290)
1. CBL enhances breast tumor formation by inhibiting tumor suppressive activity of TGF-β signaling. Kang JM; Park S; Kim SJ; Hong HY; Jeong J; Kim HS; Kim SJ Oncogene; 2012 Dec; 31(50):5123-31. PubMed ID: 22310290 [TBL] [Abstract][Full Text] [Related]
2. Smad2, Smad3 and Smad4 cooperate with Sp1 to induce p15(Ink4B) transcription in response to TGF-beta. Feng XH; Lin X; Derynck R EMBO J; 2000 Oct; 19(19):5178-93. PubMed ID: 11013220 [TBL] [Abstract][Full Text] [Related]
3. Mutations of the Smad4 gene in acute myelogeneous leukemia and their functional implications in leukemogenesis. Imai Y; Kurokawa M; Izutsu K; Hangaishi A; Maki K; Ogawa S; Chiba S; Mitani K; Hirai H Oncogene; 2001 Jan; 20(1):88-96. PubMed ID: 11244507 [TBL] [Abstract][Full Text] [Related]
4. SKI knockdown inhibits human melanoma tumor growth in vivo. Chen D; Lin Q; Box N; Roop D; Ishii S; Matsuzaki K; Fan T; Hornyak TJ; Reed JA; Stavnezer E; Timchenko NA; Medrano EE Pigment Cell Melanoma Res; 2009 Dec; 22(6):761-72. PubMed ID: 19845874 [TBL] [Abstract][Full Text] [Related]
5. Suppression of tumorigenesis and induction of p15(ink4b) by Smad4/DPC4 in human pancreatic cancer cells. Peng B; Fleming JB; Breslin T; Grau AM; Fojioka S; Abbruzzese JL; Evans DB; Ayers D; Wathen K; Wu T; Robertson KD; Chiao PJ Clin Cancer Res; 2002 Nov; 8(11):3628-38. PubMed ID: 12429655 [TBL] [Abstract][Full Text] [Related]
9. Hepatitis B virus X protein shifts human hepatic transforming growth factor (TGF)-beta signaling from tumor suppression to oncogenesis in early chronic hepatitis B. Murata M; Matsuzaki K; Yoshida K; Sekimoto G; Tahashi Y; Mori S; Uemura Y; Sakaida N; Fujisawa J; Seki T; Kobayashi K; Yokote K; Koike K; Okazaki K Hepatology; 2009 Apr; 49(4):1203-17. PubMed ID: 19263472 [TBL] [Abstract][Full Text] [Related]
10. c-Cbl-mediated neddylation antagonizes ubiquitination and degradation of the TGF-β type II receptor. Zuo W; Huang F; Chiang YJ; Li M; Du J; Ding Y; Zhang T; Lee HW; Jeong LS; Chen Y; Deng H; Feng XH; Luo S; Gao C; Chen YG Mol Cell; 2013 Feb; 49(3):499-510. PubMed ID: 23290524 [TBL] [Abstract][Full Text] [Related]
11. H19 non coding RNA-derived miR-675 enhances tumorigenesis and metastasis of breast cancer cells by downregulating c-Cbl and Cbl-b. Vennin C; Spruyt N; Dahmani F; Julien S; Bertucci F; Finetti P; Chassat T; Bourette RP; Le Bourhis X; Adriaenssens E Oncotarget; 2015 Oct; 6(30):29209-23. PubMed ID: 26353930 [TBL] [Abstract][Full Text] [Related]
12. Mucin1 shifts Smad3 signaling from the tumor-suppressive pSmad3C/p21(WAF1) pathway to the oncogenic pSmad3L/c-Myc pathway by activating JNK in human hepatocellular carcinoma cells. Li Q; Liu G; Yuan H; Wang J; Guo Y; Chen T; Zhai R; Shao D; Ni W; Tai G Oncotarget; 2015 Feb; 6(6):4253-65. PubMed ID: 25714018 [TBL] [Abstract][Full Text] [Related]
13. Oncogenic function of a novel WD-domain protein, STRAP, in human carcinogenesis. Halder SK; Anumanthan G; Maddula R; Mann J; Chytil A; Gonzalez AL; Washington MK; Moses HL; Beauchamp RD; Datta PK Cancer Res; 2006 Jun; 66(12):6156-66. PubMed ID: 16778189 [TBL] [Abstract][Full Text] [Related]
14. Oncogenic Smad3 signaling induced by chronic inflammation is an early event in ulcerative colitis-associated carcinogenesis. Kawamata S; Matsuzaki K; Murata M; Seki T; Matsuoka K; Iwao Y; Hibi T; Okazaki K Inflamm Bowel Dis; 2011 Mar; 17(3):683-95. PubMed ID: 20602465 [TBL] [Abstract][Full Text] [Related]
15. Targeting the E3 ubiquitin casitas B-lineage lymphoma decreases osteosarcoma cell growth and survival and reduces tumorigenesis. Sévère N; Dieudonné FX; Marty C; Modrowski D; Patiño-García A; Lecanda F; Fromigué O; Marie PJ J Bone Miner Res; 2012 Oct; 27(10):2108-17. PubMed ID: 22623369 [TBL] [Abstract][Full Text] [Related]
16. Cutting edge: deficiency in the E3 ubiquitin ligase Cbl-b results in a multifunctional defect in T cell TGF-beta sensitivity in vitro and in vivo. Wohlfert EA; Gorelik L; Mittler R; Flavell RA; Clark RB J Immunol; 2006 Feb; 176(3):1316-20. PubMed ID: 16424156 [TBL] [Abstract][Full Text] [Related]
17. Protumorigenic actions of S100A2 involve regulation of PI3/Akt signaling and functional interaction with Smad3. Naz S; Bashir M; Ranganathan P; Bodapati P; Santosh V; Kondaiah P Carcinogenesis; 2014 Jan; 35(1):14-23. PubMed ID: 23996929 [TBL] [Abstract][Full Text] [Related]
18. The E3 ubiquitin ligase Cbl-b improves the prognosis of RANK positive breast cancer patients by inhibiting RANKL-induced cell migration and metastasis. Zhang L; Teng Y; Fan Y; Wang Y; Li W; Shi J; Ma Y; Li C; Shi X; Qu X; Liu Y Oncotarget; 2015 Sep; 6(26):22918-33. PubMed ID: 26087197 [TBL] [Abstract][Full Text] [Related]
19. Smad2 and Smad3 have opposing roles in breast cancer bone metastasis by differentially affecting tumor angiogenesis. Petersen M; Pardali E; van der Horst G; Cheung H; van den Hoogen C; van der Pluijm G; Ten Dijke P Oncogene; 2010 Mar; 29(9):1351-61. PubMed ID: 20010874 [TBL] [Abstract][Full Text] [Related]
20. Casitas B-lineage lymphoma mutants activate AKT to induce transformation in cooperation with class III receptor tyrosine kinases. Polzer H; Janke H; Schmid D; Hiddemann W; Spiekermann K Exp Hematol; 2013 Mar; 41(3):271-80.e4. PubMed ID: 23127761 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]